What Are the Main Causes of Urticaria (Hives)?
Title: What Are the Main Causes of Urticaria (Hives)?Category: Diseases and ConditionsCreated: 1/12/2021 12:00:00 AMLast Editorial Review: 1/12/2021 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - January 12, 2021 Category: Allergy & Immunology Source Type: news

Health and well-being harms experienced by adult victims of interpersonal violence: a scoping review protocol - Olive P, Hives L, Wilson N, Nowland R, Clegg A.
OBJECTIVE: The purpose of this scoping review is to identify the extent of research exploring the health and well-being harms experienced by adult victims of different types of interpersonal violence. INTRODUCTION: Interpersonal violence is define... (Source: SafetyLit)
Source: SafetyLit - January 6, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Brain gene expression patterns predict behavior of individual honey bees
(University of Illinois at Urbana-Champaign, News Bureau) An unusual study that involved bar coding and tracking the behavior of thousands of individual honey bees in six queenless bee hives and analyzing gene expression in their brains offers new insights into how gene regulation contributes to social behavior. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 22, 2020 Category: International Medicine & Public Health Source Type: news

Are Hives Urticaria Contagious
Are Hives (Urticaria) Contagious? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 17, 2020 Category: General Medicine Source Type: news

FDA approves Xolair ® (omalizumab) for adults with nasal polyps
             Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.1 Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this ap...
Source: Roche Investor Update - December 1, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Xolair ® (omalizumab) for adults with nasal polyps
             Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.1 Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this ap...
Source: Roche Media News - December 1, 2020 Category: Pharmaceuticals Source Type: news

How to Get Rid of Hives: 20 Ways
Title: How to Get Rid of Hives: 20 WaysCategory: Diseases and ConditionsCreated: 11/16/2020 12:00:00 AMLast Editorial Review: 11/16/2020 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - November 16, 2020 Category: Dermatology Source Type: news

‘Covid Toes’, Rashes, And Hives: New Research Underpins Covid-19’s Long-Term Skin Impact
Researchers have identified a set of skin complaints following Covid-19 infection. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 29, 2020 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Editors' Pick editors-pick Breaking breaking-news Coronavirus Source Type: news

What Is Causing My Hives?
Title: What Is Causing My Hives?Category: Diseases and ConditionsCreated: 10/16/2020 12:00:00 AMLast Editorial Review: 10/16/2020 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - October 16, 2020 Category: Allergy & Immunology Source Type: news

SIMPONI ARIA ® (golimumab) Approved by the U.S. Food and Drug Administration for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older
HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This latest FDA approval of SIMPONI ARIA for pediatric use in active pJIA and active PsA not only brings a new option to young patients living with these diseases but also adds to the growing body of evidence for this treatment,” said Mathai Mammen, M.D., Ph.D., Glo...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Source Type: news

Covid-19 skin rash website criticised for lack of BAME examples
Only two out of 400 Covid images on British Association of Dermatologists ’ website feature black or brown skinCoronavirus – latest updatesSee all our coronavirus coverageA website dedicated to sharing images of Covid-19-related skin rashes to help doctors and patients identify whether an unusual rash might be a sign of coronavirus infection has been criticised for containing just two images of black or brown skin.The British Association of Dermatologists ’ (BAD)Covid-19 Skin Patternswebsite features 400 images of Covid-associated rashes, from prickly heat and chickenpox-type rashes to raised itchy hives ...
Source: Guardian Unlimited Science - September 28, 2020 Category: Science Authors: Linda Geddes Tags: Coronavirus outbreak Race Science UK news Source Type: news

What Is Causing My Hives
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 23, 2020 Category: General Medicine Source Type: news

What is the Allergen Cross-Reactivity Rate of Legumes?
Discussion There are 8 common foods which compromise 90% of food allergens with those being peanuts, soybeans, cow’s milk, eggs, fish, crustacean/shellfish, wheat and tree nuts. Some people believe that lupin (a legume) is 9th. Legumes belong to the Fabaceae family. They provide protein, fat, vitamins other essential nutrients and therefore are used in the human diet throughout the world. “[A]llergenicity due to consumption of legumes in decreasing order may be peanut, soybean, lentil, chickpea, pea, mung bean and red gram.” Other common legumes include alfalfa, clovers, beans, lupins, mesquite, carob...
Source: PediatricEducation.org - September 14, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

FDA accepts application for Xolair (omalizumab) prefilled syringe for self-administration across all indications
Basel, 13 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) accepted the company ’s supplemental Biologics License Application (sBLA) for a new self-administration option for Xolair® (omalizumab) across all approved US indications. If approved, Xolair prefilled syringe would become available for either self-administration by select patients or administration by their caregivers. A decision on approval is anticipated by Q1 2021. In the US, Xolair is currently approved for administration by a healthcare provider in a healthcare setting, and is the only a...
Source: Roche Investor Update - August 13, 2020 Category: Pharmaceuticals Source Type: news

Lead released in Notre Dame Cathedral fire detected in Parisian honey
(University of British Columbia) Elevated levels of lead have been found in samples of honey from hives downwind of the Notre Dame Cathedral fire, collected three months after the April 2019 blaze. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 29, 2020 Category: Biology Source Type: news

TREMFYA ® (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis
HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] TREMFYA is the first treatment approved for active PsA that selectively inhibits interleukin (IL)-23, a naturally occurring cytokine that is involved in normal inflammatory and immune responses associated with the symptoms of PsA. The safety and efficacy of TREMFYA in PsA have b...
Source: Johnson and Johnson - July 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Fatigue and sleep patterns among Canadian wildland firefighters during a 17-day fire line deployment - Jeklin AT, Davies HW, Bredin SSD, Hives BA, Meanwell LE, Perrotta AS, Warburton DER.
The purpose of this investigation was to enhance our understanding of the effects the current British Columbia Wildfire Service (BCWS) firefighting schedule have on the development of fatigue and sleep deprivation. This was a cohort study that objectively ... (Source: SafetyLit)
Source: SafetyLit - June 2, 2020 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

What Is the Main Cause of Urticaria
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 28, 2020 Category: General Medicine Source Type: news

Insect Experts Say People Should Calm Down About the Threat of ‘Murder Hornets’
Insect experts say people should calm down about the big bug with the nickname “murder hornet” — unless you are a beekeeper or a honeybee. The Asian giant hornets found in Washington state that grabbed headlines this week aren’t big killers of humans, although it does happen on rare occasions. But the world’s largest hornets do decapitate entire hives of honeybees, and that crucial food pollinator is already in big trouble. Numerous bug experts told The Associated Press that what they call hornet “hype” reminds them of the 1970s public scare when Africanized honeybees, nicknamed &l...
Source: TIME: Science - May 7, 2020 Category: Science Authors: Seth Borenstein / AP Tags: Uncategorized Environment News Desk wire Source Type: news

Singapore Was a Coronavirus Success Story —Until an Outbreak Showed How Vulnerable Workers Can Fall Through the Cracks
Since mid-March, Asadul Alam Asif has watched nervously as Singapore reported more and more COVID-19 cases in migrant workers’ dormitories like the one where he lives. The 28-year-old Bangladeshi technician counted himself lucky each day that nobody was infected in his housing block, where around 1,900 workers reside in cramped conditions that make social distancing impossible. To relieve congestion, Asif’s company rehoused some people, which left half of the 16 bunk-beds in his small room empty. But then, one day last week, seven people in Asif’s dorm tested positive. He received a text message instru...
Source: TIME: Health - April 29, 2020 Category: Consumer Health News Authors: Hillary Leung Tags: Uncategorized COVID-19 feature News Desk overnight Source Type: news

From ‘COVID Toes’ to Hives, These Are the Skin Conditions Dermatologists Think Could Be Signs of Coronavirus
Dermatologists around the world are gathering data on what may be largely overlooked symptoms of COVID-19: skin conditions ranging from rashes to “pseudo-frostbite.” Many viral illnesses—including chickenpox, measles and mononucleosis—are accompanied by telltale skin rashes, often a result of the body’s heightened inflammatory response while fighting off infection. Though more research is needed, a growing number of case reports and preliminary studies suggest SARS-CoV-2, the virus that causes COVID-19, can also affect the skin. In late March, an Italian physician submitted a letter to the edi...
Source: TIME: Health - April 28, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news

Virus-infected honey bees more likely to gain entrance to healthy hives
(University of Illinois at Urbana-Champaign, News Bureau) Honey bees that guard hive entrances are twice as likely to allow in trespassers from other hives if the intruders are infected with the Israeli acute paralysis virus, a deadly pathogen of bees, researchers report. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 27, 2020 Category: Infectious Diseases Source Type: news

Cold-induced urticarial rash -- researchers discover new hereditary disease
(Charit é - Universit ä tsmedizin Berlin) Skin rash combined with head and joint pain: these are the symptoms which patients with familial (hereditary) cold urticaria develop when exposed to temperatures below 15 ° C. Researchers from Charit é -- Universit ä tsmedizin Berlin have discovered a new, previously unknown form of this inflammatory skin disorder. In addition to explaining why conventional treatments are ineffective in some people with the disorder, their findings also point to potential alternatives. The results of this research have been published in Nature Communications*. (Source: E...
Source: EurekAlert! - Medicine and Health - April 27, 2020 Category: International Medicine & Public Health Source Type: news

‘This Is Really Life or Death.’ For People With Disabilities, Coronavirus Is Making It Harder Than Ever to Receive Care
Jeiri Flores is normally a busy, upbeat 29-year-old. But amid the COVID-19 pandemic, her go-to thought has been dark. “If I get this,” she thinks, “I’m gonna die.” This is not an unfounded fear. Flores has cerebral palsy, uses a wheelchair and needs assistance with everyday tasks, including making food and getting dressed. Her disability means it’s tougher for her immune system to kick illnesses; she’s still recovering from a bout of pneumonia she had in January. So beating COVID-19 could easily mean a protracted battle and months in a hospital—a prospect that comes with a c...
Source: TIME: Health - April 24, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news

FDA grants Breakthrough Therapy Designation for Roche ’s Esbriet (pirfenidone) in unclassifiable interstitial lung disease
Basel, 3 March 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Esbriet ® (pirfenidone) for adults with unclassifiable interstitial lung disease (uILD). The designation was granted based on data from a Phase II trial, which studied the efficacy and safety of Esbriet in uILD[1]. The study represented the first randomised controlled trial to exclusively enroll patients with progressive fibrosing uILD.“Today’s milestone for Esbriet builds on our continued commitment to improving the standard of care ...
Source: Roche Investor Update - March 3, 2020 Category: Pharmaceuticals Source Type: news

Brief Update on Dermatologic Uses of Methotrexate Brief Update on Dermatologic Uses of Methotrexate
This review explores established and emerging clinical indications for methotrexate in dermatological conditions, including psoriasis, blistering diseases, chronic urticaria, slceroderma, and more.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 24, 2020 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

FDA Approves First Drug To Treat Peanut Allergies In Children
(CNN) — The US Food and Drug Administration approved the first drug to treat peanut allergies in children on Friday, following an advisory committee vote of approval in September. The drug, Palforzia, can be used for children between 4 and 17 years old. It’s designed to minimize the incidence and severity of a child’s allergic reaction to peanuts, as even a small amount of exposure can be harmful to children with the allergy. Children are left attempting to avoid exposure to peanuts to avoid reactions. Though that will continue to be necessary with Palforzia, the risk of a reaction will be lessened, says ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 3, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Peanut Allergy Source Type: news

Into pharma's roaring twenties
“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back down to ground level just in time to see the man draw back his fist in anger, and then.And then.With a piercing shriek, he lunged straight at my jaw –”Do you ever wake from a dream, marvelling at the inventiveness and detail of your subconscious mind? That disorienting moment where you lie blinking ...
Source: EyeForPharma - January 14, 2020 Category: Pharmaceuticals Authors: Paul Simms Source Type: news

Into pharma's roaring twenties
“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back down to ground level just in time to see the man draw back his fist in anger, and then.And then.With a piercing shriek, he lunged straight at my jaw –”Do you ever wake from a dream, marvelling at the inventiveness and detail of your subconscious mind? That disorienting moment where you lie blinking ...
Source: EyeForPharma - January 14, 2020 Category: Pharmaceuticals Authors: Paul Simms Source Type: news

Into pharma's roaring twenties
“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back down to ground level just in time to see the man draw back his fist in anger, and then.And then.With a piercing shriek, he lunged straight at my jaw –”Do you ever wake from a dream, marvelling at the inventiveness and detail of your subconscious mind? That disorienting moment where you lie blinking ...
Source: EyeForPharma - January 14, 2020 Category: Pharmaceuticals Authors: Paul Simms Source Type: news

Health Tip: Allergic Reaction First Aid
-- Allergic reactions are sensitivities to allergens. From animal dander to foods, allergens may cause hives, itching, a rash and other symptoms. For a mild-to-moderate reaction, MedlinePlus mentions these first aid steps: Calm and reassure the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 3, 2020 Category: General Medicine Source Type: news

How bees could help lower your blood pressure
University of Plymouth researchers have found that a mouthwash made from a material bees use to waterproof their hives could help combat high blood pressure and gum disease. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2019 Category: Consumer Health News Source Type: news

Canadian woman who is allergic to the COLD fears for her life going outside
Emma Brown, 18, of Edmonton, has the condition cold urticaria. She fears going outside alone in case she falls over and gets stuck. Her throat may swell up, restricting her breathing. (Source: the Mail online | Health)
Source: the Mail online | Health - November 28, 2019 Category: Consumer Health News Source Type: news

Student who is allergic to WATER breaks out in rashes when she cries or sweats
Tessa Hansen-Smith, from California, suffers from aquagenic urticaria, an extremely rare condition thought to affect fewer than 100 people in the world. (Source: the Mail online | Health)
Source: the Mail online | Health - November 27, 2019 Category: Consumer Health News Source Type: news

Health Tip: Living With Nut Allergy
-- From hives and itchiness to anaphylaxis, an allergic reaction to nuts can manifest itself in many ways, says the University of Rochester. If you are living with a nut allergy, the school suggests: When grocery shopping, check every item's... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 25, 2019 Category: General Medicine Source Type: news

Seven-year-old with rare condition breaks out in a rash, vomits and struggles to breathe when cold
Tommy Leitch, of Amersham, had to be hospitalised every month last winter, his mother, Abigail McDonald, said. He suffers with urticaria and angioedema, which cause hives and swelling. (Source: the Mail online | Health)
Source: the Mail online | Health - October 17, 2019 Category: Consumer Health News Source Type: news

FDA OKs Cetirizine Injection (Quzyttir) for Acute Urticaria FDA OKs Cetirizine Injection (Quzyttir) for Acute Urticaria
Cetirizine hydrochloride (10 mg/mL) intravenous injection is for treatment of acute urticaria in adults and children 6 months of age or older.FDA Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - October 15, 2019 Category: Internal Medicine Tags: Dermatology News Alert Source Type: news

FDA Approves Quzyttir (cetirizine) Injection for the Treatment of Acute Urticaria
October 11, 2019 - The U.S. Food and Drug Administration (FDA) has approved Quzyttir (cetirizine hydrochloride) injection for the treatment of acute urticaria in adults and children 6 months of age and older. Quzyttir will be available as 10-mg/mL... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 11, 2019 Category: Drugs & Pharmacology Source Type: news

Ligelizumab Safely, Effectively Treats Hives
THURSDAY, Oct. 3, 2019 -- Ligelizumab appears to be a safe and effective treatment option for chronic spontaneous urticaria, according to a study published in the Oct. 3 issue of the New England Journal of Medicine. In a phase 2b dose-finding study,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 3, 2019 Category: Pharmaceuticals Source Type: news

Ligelizumab May Improve Response in Chronic Urticaria Ligelizumab May Improve Response in Chronic Urticaria
Early trial results suggest the investigational humanized anti-IgE monoclonal antibody ligelizumab binds to IgE with greater affinity than FDA-approved omalizumab for refractory chronic spontaneous urticaria.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 3, 2019 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Ditch the Itch: Researchers Find New Drug to Fight Hives
Title: Ditch the Itch: Researchers Find New Drug to Fight HivesCategory: Health NewsCreated: 10/2/2019 12:00:00 AMLast Editorial Review: 10/3/2019 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - October 3, 2019 Category: Allergy & Immunology Source Type: news

Ditch the Itch: Researchers Find New Trial Drug, Ligelizumab, to Fight Hives
WEDNESDAY, Oct. 2, 2019 -- A new drug to treat chronic hives is producing solid results in clinical trials, and could be available to people suffering with the maddening itchy welts within a year or so, researchers say. Ligelizumab works by... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 2, 2019 Category: General Medicine Source Type: news

Letter to the Editor: Questions about Antihistamines for Hives
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - October 1, 2019 Category: Emergency Medicine Tags: Letter to the Editor Source Type: news

What Affects the Nutritional Quality of Plant-Based Milk Substitutes?
Discussion People today may be eating more plant-based products because of: Allergen avoidance – lactose or cow’s milk allergy, 14% of people with cow’s milk allergy will also have soy allergy. Cultural importance Contamination avoidance e.g. growth hormone or antibiotic residues in cow’s milk production Specific diseases, e.g. cholesterol/lipid issues Environmental impact Ethical or religious considerations Improved nutrition With population growth “[t]he demand for food is expected to grow by 70% until 2050….While the expected protein consumption is believed to grow by 80%.” ...
Source: PediatricEducation.org - September 30, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

ASK THE GP: Why hives could be a reaction to diabetes drug! DR MARTIN SCURR answers your questions
ASK THE GP: Six years ago, I was diagnosed with a low white blood cell count. I've been suffering from thrush and hives for around four-and-a-half years. Could these problems be linked? (Source: the Mail online | Health)
Source: the Mail online | Health - September 9, 2019 Category: Consumer Health News Source Type: news

Health Tip: Managing a Poison Ivy Rash
-- A poison ivy rash is caused by coming in contact with the oil found in the plant. The rash is very itchy and can be accompanied by redness, swelling, hives and crusting skin, says the American Academy of Dermatology. To manage a poison ivy rash,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 2, 2019 Category: General Medicine Source Type: news

Why Parents Are Turning to a Controversial Treatment for Food Allergies
This article was originally published on Undark. Read the original article. (Source: TIME: Health)
Source: TIME: Health - August 15, 2019 Category: Consumer Health News Authors: Esther Landhuis / Undark Tags: Uncategorized allergies health onetime syndication Source Type: news

Vitamin D Treatment for Chronic Urticaria Vitamin D Treatment for Chronic Urticaria
Is there an association of chronic urticaria with vitamin D deficiency?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 31, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news